EYE Insider Trading

Insider Ownership Percentage: 18.59%
Insider Buying (Last 12 Months): A$11,740.95
Insider Selling (Last 12 Months): A$0.00

Nova Eye Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Nova Eye Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nova Eye Medical Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 01/1/2000 01:00 AM ET

This chart shows the closing price history over time for EYE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Nova Eye Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/1/2025Thomas (Tom) SpurlingInsiderBuy78,273A$0.15A$11,740.95
5/5/2023Rahmon CoupeInsiderBuy277,778A$0.18A$50,000.04
See Full Table

SEC Filings (Institutional Ownership Changes) for Nova Eye Medical (ASX:EYE)

18.73% of Nova Eye Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Nova Eye Medical logo
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Read More on Nova Eye Medical

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

A$34.22 million

P/E Ratio

N/A

Dividend Yield

1.23%

Beta

0.96

Who are the company insiders with the largest holdings of Nova Eye Medical?

Nova Eye Medical's top insider investors include:
  1. Thomas (Tom) Spurling (Insider)
Learn More about top insider investors at Nova Eye Medical.